Search Ontology:
ChEBI

ruxolitinib

Term ID
CHEBI:66919
Synonyms
  • (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile
  • INCB018424
  • ruxolitinib
Definition
A pyrazole substituted at position 1 by a 2-cyano-1-cyclopentylethyl group and at position 3 by a pyrrolo[2,3-d]pyrimidin-4-yl group. Used as the phosphate salt for the treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis.
References
  • cas:941678-49-5
  • drugcentral:4190
  • kegg.drug:D09959
  • lincs.smallmolecule:LSM-1139
  • patent:US2008312258
  • patent:US2010190981
  • pubmed:21602517
  • pubmed:21919691
  • pubmed:21926964
  • pubmed:22034658
  • pubmed:22227528
  • pubmed:22279053
  • pubmed:22281165
  • pubmed:22375970
  • pubmed:22375971
  • pubmed:22399854
  • pubmed:22422826
  • pubmed:22474318
  • pubmed:22544377
  • pubmed:22718840
  • pubmed:22830345
  • reaxys:18703668
  • wikipedia.en:Ruxolitinib
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from ruxolitinib
Phenotype where environments contain ruxolitinib
Phenotype modified by environments containing ruxolitinib
Phenotype affecting ruxolitinib
Human Disease Model